Alun Bermingham

1.2k total citations
16 papers, 775 citations indexed

About

Alun Bermingham is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Alun Bermingham has authored 16 papers receiving a total of 775 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Infectious Diseases. Recurrent topics in Alun Bermingham's work include Biochemical and Molecular Research (5 papers), Signaling Pathways in Disease (4 papers) and HIV/AIDS drug development and treatment (4 papers). Alun Bermingham is often cited by papers focused on Biochemical and Molecular Research (5 papers), Signaling Pathways in Disease (4 papers) and HIV/AIDS drug development and treatment (4 papers). Alun Bermingham collaborates with scholars based in United States, United Kingdom and Canada. Alun Bermingham's co-authors include Jeremy P. Derrick, Walter H.J. Ward, Geoffrey A. Holdgate, Barry R. O’Keefe, John A. Beutler, Patrick A. Plé, Gerard Costello, Robert W. Wilkinson, Brigitte Boyer and Barry R. Davies and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Alun Bermingham

16 papers receiving 767 citations

Peers

Alun Bermingham

ONCOL

EPIDE

Claudio Zamperini Italy

Paul Tawa United States

Ming‐Yi Ho Taiwan

Chen‐Chen Kan United States

Stephen J. Headey Australia

Norman Kairies Germany

Hongjing Qu United States

Urša Pečar Fonović Slovenia

Jenefer Alam Singapore

D. H. RICH United States

Claudio Zamperini Italy

Alun Bermingham

446 ×0.8

146 ×0.8

90 ×0.6

ONCOL

429 ×3.3

86 ×0.9

EPIDE

Citations per year, relative to Alun Bermingham Alun Bermingham (= 1×) peers Claudio Zamperini

Countries citing papers authored by Alun Bermingham

Since Specialization

Citations

This map shows the geographic impact of Alun Bermingham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alun Bermingham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alun Bermingham more than expected).

Fields of papers citing papers by Alun Bermingham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alun Bermingham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alun Bermingham. The network helps show where Alun Bermingham may publish in the future.

Co-authorship network of co-authors of Alun Bermingham

This figure shows the co-authorship network connecting the top 25 collaborators of Alun Bermingham. A scholar is included among the top collaborators of Alun Bermingham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alun Bermingham. Alun Bermingham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Nichols, Robert J., Yu Chi Yang, Jim Cregg, et al.. (2022). Abstract 3595: RMC-6291, a next-generation tri-complex KRASG12C(ON) inhibitor, outperforms KRASG12C(OFF) inhibitors in preclinical models of KRASG12C cancers. Cancer Research. 82(12_Supplement). 3595–3595. 27 indexed citations

Gustafson, W. Clay, David Wildes, Meghan A. Rice, et al.. (2022). Direct targeting of RAS in pancreatic ductal adenocarcinoma with RMC-6236, a first-in-class, RAS-selective, orally bioavailable, tri-complex RAS^MULTI(ON) inhibitor.. Journal of Clinical Oncology. 40(4_suppl). 591–591. 23 indexed citations

Schulze, Christopher J., Jim Cregg, Kyle J. Seamon, et al.. (2022). Abstract 3598: A first-in-class tri-complex KRASG13C(ON) inhibitor validates therapeutic targeting of KRASG13Cand drives tumor regressions in preclinical models. Cancer Research. 82(12_Supplement). 3598–3598. 9 indexed citations

Krumpe, Lauren R. H., Brice A. P. Wilson, Christophe Marchand, et al.. (2020). Recifin A, Initial Example of the Tyr-Lock Peptide Structural Family, Is a Selective Allosteric Inhibitor of Tyrosyl-DNA Phosphodiesterase I. Journal of the American Chemical Society. 142(50). 21178–21188. 17 indexed citations

Schulze, Christopher J., Alun Bermingham, Tiffany J. Choy, et al.. (2019). Abstract PR10: Tri-complex inhibitors of the oncogenic, GTP-bound form of KRASG12C overcome RTK-mediated escape mechanisms and drive tumor regressions in vivo. Molecular Cancer Therapeutics. 18(12_Supplement). PR10–PR10. 15 indexed citations

Bermingham, Alun, Edmund V. Price, Christophe Marchand, et al.. (2017). Identification of Natural Products That Inhibit the Catalytic Function of Human Tyrosyl-DNA Phosphodiesterase (TDP1). SLAS DISCOVERY. 22(9). 1093–1105. 19 indexed citations

Bermingham, Alun, et al.. (2014). A screen for the identification of inhibitors of tyrosyl-DNA phosphodiesterase 1. Planta Medica. 80(10). 1 indexed citations

Antczak, Christophe, Alun Bermingham, Dmitry Malkov, et al.. (2012). Domain-Based Biosensor Assay to Screen for Epidermal Growth Factor Receptor Modulators in Live Cells. Assay and Drug Development Technologies. 10(1). 24–36. 27 indexed citations

Chung, Suhman, Michaela Wendeler, Jason W. Rausch, et al.. (2010). Structure-Activity Analysis of Vinylogous Urea Inhibitors of Human Immunodeficiency Virus-Encoded Ribonuclease H. Antimicrobial Agents and Chemotherapy. 54(9). 3913–3921. 42 indexed citations

10.

Green, Tim P., Jon Curwen, Vivien N. Jacobs, et al.. (2009). Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530. Molecular Oncology. 3(3). 248–261. 176 indexed citations

11.

Wendeler, Michaela, Hsiu-Fang Lee, Alun Bermingham, et al.. (2008). Vinylogous Ureas as a Novel Class of Inhibitors of Reverse Transcriptase-Associated Ribonuclease H Activity. ACS Chemical Biology. 3(10). 635–644. 53 indexed citations

12.

Takada, Kentaro, Alun Bermingham, Barry R. O’Keefe, et al.. (2007). An HIV RNase H Inhibitory 1,3,4,5-Tetragalloylapiitol from the African Plant Hylodendron gabunensis. Journal of Natural Products. 70(10). 1647–1649. 18 indexed citations

13.

Sullivan, Jane E., Geoffrey A. Holdgate, Douglas A. Campbell, et al.. (2005). Prevention of MKK6-Dependent Activation by Binding to p38α MAP Kinase. Biochemistry. 44(50). 16475–16490. 75 indexed citations

14.

Bermingham, Alun, et al.. (2004). Kinetic and structural characterization of a product complex of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase from Escherichia coli. Biochemical Journal. 380(3). 867–873. 9 indexed citations

15.

Bermingham, Alun & Jeremy P. Derrick. (2002). The folic acid biosynthesis pathway in bacteria: evaluation of potential for antibacterial drug discovery. BioEssays. 24(7). 637–648. 229 indexed citations

16.

Bermingham, Alun, Joanna Bottomley, William U. Primrose, & Jeremy P. Derrick. (2000). Equilibrium and Kinetic Studies of Substrate Binding to 6-Hydroxymethyl-7,8-dihydropterin Pyrophosphokinase fromEscherichia coli. Journal of Biological Chemistry. 275(24). 17962–17967. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact